status,city,state,country,classification,openfda/application_number/0,openfda/brand_name/0,openfda/generic_name/0,openfda/manufacturer_name/0,openfda/product_ndc/0,openfda/product_type/0,openfda/route/0,openfda/substance_name/0,openfda/rxcui/0,openfda/rxcui/1,openfda/spl_id/0,openfda/spl_set_id/0,openfda/package_ndc/0,openfda/is_original_packager/0,openfda/unii/0,openfda/upc/0,product_type,event_id,recalling_firm,address_1,address_2,postal_code,voluntary_mandated,initial_firm_notification,distribution_pattern,recall_number,product_description,product_quantity,reason_for_recall,recall_initiation_date,center_classification_date,termination_date,report_date,code_info,more_code_info,openfda/product_ndc/1,openfda/product_ndc/2,openfda/rxcui/2,openfda/package_ndc/1,openfda/package_ndc/2,openfda/package_ndc/3,openfda/package_ndc/4,openfda/package_ndc/5,openfda/package_ndc/6,openfda/package_ndc/7,openfda/package_ndc/8,openfda/package_ndc/9,openfda/package_ndc/10,openfda/package_ndc/11,openfda/route/1,openfda/upc/1,openfda/upc/2,openfda/product_ndc/3,openfda/product_ndc/4,openfda/package_ndc/12,openfda/package_ndc/13,openfda/package_ndc/14,openfda/package_ndc/15,openfda/package_ndc/16,openfda/package_ndc/17,openfda/package_ndc/18,openfda/package_ndc/19,openfda/rxcui/3,openfda/nui/0,openfda/nui/1,openfda/pharm_class_cs/0,openfda/pharm_class_epc/0,openfda/product_ndc/5,openfda/product_ndc/6,openfda/product_ndc/7,openfda/product_ndc/8,openfda/product_ndc/9,openfda/product_ndc/10,openfda/product_ndc/11,openfda/rxcui/4,openfda/rxcui/5,openfda/rxcui/6,openfda/rxcui/7,openfda/rxcui/8,openfda/rxcui/9,openfda/rxcui/10,openfda/rxcui/11,openfda/package_ndc/20,openfda/package_ndc/21,openfda/package_ndc/22,openfda/package_ndc/23,openfda/upc/3,openfda/upc/4,openfda/upc/5,openfda/upc/6,openfda/upc/7,openfda/upc/8,openfda/upc/9,openfda/upc/10,openfda/upc/11,openfda/substance_name/1,openfda/substance_name/2,openfda/nui/2,openfda/nui/3,openfda/pharm_class_pe/0,openfda/pharm_class_pe/1,openfda/unii/1,openfda/unii/2,openfda/original_packager_product_ndc/0,openfda/original_packager_product_ndc/1,openfda/original_packager_product_ndc/2,openfda/package_ndc/24,openfda/package_ndc/25,openfda/package_ndc/26,openfda/package_ndc/27,openfda/package_ndc/28,openfda/package_ndc/29,openfda/package_ndc/30,openfda/package_ndc/31,openfda/package_ndc/32,openfda/package_ndc/33,openfda/package_ndc/34,openfda/package_ndc/35,openfda/package_ndc/36,openfda/package_ndc/37,openfda/package_ndc/38,openfda/package_ndc/39,openfda/package_ndc/40,openfda/package_ndc/41,openfda/package_ndc/42,openfda/package_ndc/43,openfda/pharm_class_moa/0,openfda/rxcui/12,openfda/rxcui/13,openfda/route/2,openfda/original_packager_product_ndc/3,openfda/pharm_class_epc/1,openfda/pharm_class_moa/1,openfda/substance_name/3,openfda/unii/3,openfda/substance_name/4,openfda/unii/4,openfda/nui/4,openfda/nui/5,openfda/pharm_class_epc/2
Terminated,Whippany,NJ,United States,Class I,M005,TINACTIN,TOLNAFTATE,Bayer HealthCare LLC.,11523-0777,HUMAN OTC DRUG,TOPICAL,TOLNAFTATE,705934,705936,289df0b8-dadb-2f63-e063-6394a90aa6f4,00a17e61-0d91-41e0-9cbe-c7c0b3093f3c,11523-0777-2,TRUE,06KB629TKV,3.11E+11,Drugs,88677,Bayer Healthcare Pharmaceuticals Inc.,100 Bayer Blvd,N/A,07981-1544,Voluntary: Firm initiated,Press Release,"Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.",D-0253-2022,"Tinactin (Tolnaftate 1%) POWDER SPRAY NET WT 133g (4.6 oz) can, labeled as (a) Product of  Ireland 86940418; (b)Product of Finland 20006106; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 3 11017 41009 7, NDC 11523-0777-2.","2,841,012 cans",Chemical Contamination: presence of benzene,20211001,20211118,20230626,20211124,"Lot # (a)CV015YS, EXP 9/30/2021  (b) TN008CT, TN007TJ, EXP 3/31/2023",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Athens,TN,United States,Class II,,,,,,,,,,,,,,,,,Drugs,95826,Midlab Incorporated,140 Private Brand Way,,37303-1401,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0090-2025,"ROYALAB Germ Away Antibacterial Hand Soap, Chloroxylenol 0.1%, NET CONTENTS: ONE U.S. GALLON (3.78 L), Royal Papers, 2701 Hereford St., St. Louis, MO 63139",,cGMP Deviations: Out of specification results for micro in hand soap products.,20241106,20241202,,20241211,Lot 0711241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,East Windsor,NJ,United States,Class II,ANDA206125,CINACALCET,CINACALCET,Aurobindo Pharma Limited,65862-831,HUMAN PRESCRIPTION DRUG,ORAL,CINACALCET HYDROCHLORIDE,432400,432401,5aadf0b6-2c49-48d4-8d22-2fbf99dbf4e6,42e99112-c402-4662-877f-9e3a84dff9f2,65862-831-30,TRUE,1K860WSG25,,Drugs,95730,Aurobindo Pharma USA Inc,279 Princeton Hightstown Rd,,08520-1401,Voluntary: Firm initiated,Letter,USA Nationwide,D-0078-2025,"Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.",3336 bottles,cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit,20241107,20241129,,20241211,"Lot #: a) CFSB23001A, Exp 03/31/2025, CFSB23002A, Exp 07/31/2025; CFSB23003A, Exp 10/31/2025; CFSB23004A, Exp 10/31/2025; b) P2300196, 12/31/2024",,65862-832,65862-833,432402,65862-831-90,65862-831-01,65862-831-05,65862-832-30,65862-832-90,65862-832-01,65862-832-05,65862-833-30,65862-833-90,65862-833-01,65862-833-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Lake Forest,IL,United States,Class II,ANDA077548,ONDANSETRON,ONDANSETRON,"Hospira, Inc.",0409-4755,HUMAN PRESCRIPTION DRUG,INTRAMUSCULAR,ONDANSETRON HYDROCHLORIDE,,,4f088755-91df-4db6-bad7-496cd0fb778a,6a11f61b-2318-4382-2b91-4366e4bb53fa,0409-4755-18,TRUE,NMH84OZK2B,,Drugs,65300,"Hospira, Inc.",600 N Field Dr Bldg J45,N/A,60045,Voluntary: Firm initiated,Letter,Nationwide,D-851-2013,"Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDC 0409-4755-03, Hospira, Inc, Lake Forest, IL 60045.","340,600 vials",Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot,20130520,20130807,20141028,20130814,"Lot 25394DK, exp. 01/2015",,0409-4759,,,0409-4755-03,0409-4759-01,,,,,,,,,,INTRAVENOUS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Whippany,NJ,United States,Class II,M005,TINACTIN,TOLNAFTATE,Bayer HealthCare LLC.,11523-4162,HUMAN OTC DRUG,TOPICAL,TOLNAFTATE,705934,705936,289f4a63-0291-b92a-e063-6394a90a6625,5f95be36-6efa-4dfb-9a40-88f4ce1de2b3,11523-4162-1,TRUE,06KB629TKV,3.11E+11,Drugs,88677,Bayer Healthcare Pharmaceuticals Inc.,100 Bayer Blvd,N/A,07981-1544,Voluntary: Firm initiated,Press Release,"Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.",D-0242-2022,"Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY NET WT 133g (4.6 OZ) can, labeled as (a) UPC 3 11017-410-00 4, NDC 11523-4162-1, Product of Finland 86568411; (b) UPC 3 11017 41000 4, NDC 11523-4162-1, Product of Finland 20006105; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981","738,432 cans",cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.,20211001,20211118,20230626,20211124,"Lot # (a) TN004BW, EXP 7/31/2022,   (b) TN00678, EXP 8/31/2022; TN00679, EXP 9/30/2022;",,,,,11017-410-00,,,,,,,,,,,,3.11E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Mahwah,NJ,United States,Class II,ANDA212317,DILTIAZEM HYDROCHLORIDE,DILTIAZEM HYDROCHLORIDE,"GLENMARK PHARMACEUTICALS INC., USA",68462-562,HUMAN PRESCRIPTION DRUG,ORAL,DILTIAZEM HYDROCHLORIDE,830865,830869,52b392c0-72cb-4a91-8d27-5cacdb8a7778,fb1606ea-1cff-46fd-b8e5-8135da76436c,68462-850-01,TRUE,OLH94387TE,3.68E+11,Drugs,95660,"Glenmark Pharmaceuticals Inc., USA",750 Corporate Dr,,07430-2009,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0095-2025,"Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Rx Only, 100 Capsules, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-562-01.",25584 bottles,cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.,20241101,20241203,,20241211,"Lot #: 17222470, 17230680, 17222547, Exp. Date 11/30/2024; 17230304, Exp. Date, 12/31/2024; 17230598, Exp. Date, 02/2025.",,68462-850,68462-851,830872,68462-851-01,68462-562-01,,,,,,,,,,,3.68E+11,3.68E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Zebulon,NC,United States,Class III,M001,TUMS,CALCIUM CARBONATE,Haleon US Holdings LLC,0135-0118,HUMAN OTC DRUG,ORAL,CALCIUM CARBONATE,308892,1044524,5588a55e-0349-469e-9fee-1cc0c9429966,f4786707-a0f7-4ba8-9656-06278d1b4b6c,0135-0118-01,TRUE,H0G9379FGK,,Drugs,65856,"GlaxoSmithKline, LLC.",1011 North Arendell Ave,N/A,27597-1217,Voluntary: Firm initiated,Letter,U.S. Nationwide,D-850-2013,"TUMS, Antacid/Calcium Supplement, ULTRA Strength 1000, Assorted Berries, 72 Chewable Tablets, GlaxoSmithKline, Moon Twp, PA 15108,  NDC 0135-0181-02","300,480 bottles","Presence of Foreign Tablets/Capsules: Product labeled TUMS Ultra Assorted Berries 1000mg Chewable tables, may contain EX TUMS Assorted Berries 750mg tablets",20130718,20130807,20160518,20130814,Lot 3C11 and 3C11A,,0135-0180,0135-0181,,0135-0118-04,0135-0118-14,0135-0118-83,0135-0180-01,0135-0180-02,0135-0180-14,0135-0181-01,0135-0181-02,0135-0181-03,0135-0181-05,0135-0181-06,,,,0135-0228,0135-0540,0135-0181-07,0135-0181-14,0135-0228-01,0135-0228-04,0135-0228-05,0135-0228-06,0135-0228-07,0135-0540-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Whippany,NJ,United States,Class II,M005,LOTRIMIN DAILY PREVENTION DEO,TOLNAFTATE,Bayer HealthCare LLC.,11523-0010,HUMAN OTC DRUG,TOPICAL,TOLNAFTATE,705934,,289dbd00-e2f2-0998-e063-6394a90ae1a4,9e8bfb78-ad81-93d0-e053-2995a90aa41d,11523-0010-1,TRUE,06KB629TKV,41100587206,Drugs,88677,Bayer Healthcare Pharmaceuticals Inc.,100 Bayer Blvd,N/A,07981-1544,Voluntary: Firm initiated,Press Release,"Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.",D-0240-2022,"LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray, NET WT 160g (5.6 OZ) can, packaged as (a) single pack, UPC 0 41100 58720 6, NDC 11523-0010-2; (b) 3-pack, UPC 0 41100 58961 3; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland,","579,456 cans",cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.,20211001,20211118,20230626,20211124,"Lot # (a)TN0023C, EXP 1/31/2022; TN003C7, EXP 4/30/2022; TN00570, EXP 7/31/2022; TN0056Z, TN005KJ, EXP 8/31/2022;  (b)TN0023C, EXP 01/31/2022; TN003C7, EXP 04/30/2022; TN0023DV, TN0023DAV, TN0023DBV, TN0023DC, EXP 02/28/2022; TN005KJ, TN005KJA, TN005KJB, EXP 08/31/2022;",,,,,11523-0010-2,,,,,,,,,,,,41100589613,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Mahwah,NJ,United States,Class II,ANDA212317,DILTIAZEM HYDROCHLORIDE,DILTIAZEM HYDROCHLORIDE,Northstar Rx LLC,16714-553,HUMAN PRESCRIPTION DRUG,ORAL,DILTIAZEM HYDROCHLORIDE,830865,830869,a11626b3-d7a9-43b0-85d4-38a582acd661,e2511ffe-5821-4f64-a469-f8ef9618b1b5,16714-553-01,TRUE,OLH94387TE,3.17E+11,Drugs,95660,"Glenmark Pharmaceuticals Inc., USA",750 Corporate Dr,,07430-2009,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0098-2025,"Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-555-01.",7296 bottles,cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.,20241101,20241203,,20241211,"Lot #:17222547, Exp. Date, 11/30/2024; 17230598, Exp. Date 02/28/2025",,16714-554,16714-555,830872,16714-554-01,16714-555-01,,,,,,,,,,,3.17E+11,3.17E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Shirley,NY,United States,Class II,NDA021135,VENOFER,IRON SUCROSE,"Fresenius Medical Care Holdings, Inc.",49230-530,HUMAN PRESCRIPTION DRUG,INTRAVENOUS,IRON SUCROSE,1741267,1741268,d169adb0-d1dc-4c19-99b4-f1dce90db380,f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040,49230-530-01,TRUE,FZ7NYF5N8L,3.49E+11,Drugs,95711,"American Regent, Inc.",5 Ramsey Rd,,11967-4701,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0081-2025,"Venofer (iron sucrose) Injection, USP 50 mg Elemental Iron per 2.5 mL (20 mg/mL), 2.5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02451, NDC: 49230-530-01 (vial), NDC: 49230-530-10 (10 x 2.5mL/vial cartons), NDC: 49230-530-25 (25 x 2.5mL/vial cartons).",,Presence of Particulate Matter: Potential for glass delamination from the vials.,20241111,20241129,,20241211,"Lot #s: 4206, 4210, Exp 05/31/2026; 4223, Exp 06/30/2026; 24231, 24237, Exp 07/31/2026.",,49230-534,,1741270,49230-530-10,49230-530-25,49230-534-01,49230-534-10,49230-534-25,,,,,,,,3.49E+11,,,,,,,,,,,,1741271,M0011718,N0000177913,Iron [CS],Parenteral Iron Replacement [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Raleigh,NC,United States,Class II,ANDA212399,LEVOTHYROXINE SODIUM,LEVOTHYROXINE SODIUM,Accord Healthcare Inc.,16729-447,HUMAN PRESCRIPTION DRUG,ORAL,LEVOTHYROXINE SODIUM,892246,892251,26408e81-f136-15ca-e063-6394a90a6fb6,a6233381-3043-4e9a-aaa6-a6b105e5142b,16729-458-15,TRUE,9J765S329G,3.17E+11,Drugs,95747,"ACCORD HEALTHCARE, INC.",8041 Arco Corporate Dr Ste 200,,27617-2010,Voluntary: Firm initiated,Letter,USA Nationwide,D-0076-2025,"Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-449-17",,Subpotent drug,20241108,20241129,,20241211,"Lot #: D2300191, Exp 12/31/2025",,16729-458,16729-448,892255,16729-458-17,16729-447-15,16729-447-17,16729-448-15,16729-448-17,16729-449-15,16729-449-17,16729-451-15,16729-451-17,16729-450-15,16729-450-17,,3.17E+11,3.17E+11,16729-449,16729-451,16729-452-15,16729-452-17,16729-453-15,16729-453-17,16729-454-15,16729-454-17,16729-455-15,16729-455-17,966220,,,,,16729-450,16729-452,16729-453,16729-454,16729-455,16729-456,16729-457,966221,966222,966224,966225,966248,966249,966253,966270,16729-456-15,16729-456-17,16729-457-15,16729-457-17,3.17E+11,3.17E+11,3.17E+11,3.17E+11,3.17E+11,3.17E+11,3.17E+11,3.17E+11,3.17E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Columbus,OH,United States,Class II,ANDA090778,DULOXETINE,DULOXETINE HYDROCHLORIDE,BluePoint,68001-413,HUMAN PRESCRIPTION DRUG,ORAL,DULOXETINE HYDROCHLORIDE,596926,596930,1a275613-8b5c-f2f7-e063-6294a90ac153,c9492555-6061-47bf-923e-26d4d5528453,68001-413-06,TRUE,9044SC542W,3.68E+11,Drugs,95849,Amerisource Health Services LLC,2550 John Glenn Ave Ste A,,43217-1188,Voluntary: Firm initiated,Letter,"PA, OH, PR",D-0100-2025,"Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, a) 30 count (NDC 68001-414-04) and b) 1,000 count (NDC 68001-414-08) bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories","23,490 bottles",CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit,20241114,20241203,,20241211,"a) 30 count; Lot, expiry: DT3023019B, DT3023020A, exp 01/31/2025 b) 1000 count; Lot, expiry: DTB23098A, exp 08/31/2025",,68001-414,68001-415,596934,68001-414-04,68001-414-05,68001-414-08,68001-415-04,68001-415-05,68001-415-08,,,,,,,3.68E+11,3.68E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Pennsauken,NJ,United States,Class II,,CETACAINE ANESTHETIC,"BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE","Cetylite Industries, Inc.",10223-0202,HUMAN PRESCRIPTION DRUG,TOPICAL,BENZOCAINE,543786,543789,019d3010-af34-465c-b6b0-f89b5eaec099,89f262a4-a41b-41d7-806b-61b9b89542f0,10223-0202-2,TRUE,5NF5D4OPCI,,Drugs,66012,"Cetylite Industries, Inc.",9051 River Road,N/A,08110-3203,Voluntary: Firm initiated,Letter,Nationwide,D-019-2014,"Cetacaine Liquid Topical Anesthetic,  Rx Only, a) 14 g bottle (NDC 10223-0202-2); Kit w/14 g (NDC 10223-0202-3); 30 g bottle (NDC 10223-0202-4) Manufactured by Cetylite Industries, Inc., 9051 River Road Pennsauken, NJ 08110       -",30 g - 11403 units; 14 g  - 7338 units 14 g kit - 200 units,"Subpotent Drug: Cetacaine Topical Anesthetic Liquid is being recalled because one of the three active ingredients, tetracaine, is below the specification limit  at the 21 month stability test point.",20130402,20131126,20140801,20131204,"Lot 470  exp.  04/13, 471 exp. 06/13, 472 exp.  10/13",,10223-0225,10223-0226,,10223-0202-4,10223-0202-5,10223-0202-6,10223-0202-7,10223-0202-8,10223-0225-1,10223-0226-1,10223-0202-3,,,,,,,,,,,,,,,,,,N0000185508,N0000175629,Allergens [CS],Standardized Chemical Allergen [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,BUTAMBEN,TETRACAINE HYDROCHLORIDE,N0000184306,M0000728,Increased Histamine Release [PE],Cell-mediated Immunity [PE],EFW857872Q,U3RSY48JW5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Whippany,NJ,United States,Class II,M005,LOTRIMIN,MICONAZOLE NITRATE,Bayer Healthcare LLC.,11523-0544,HUMAN OTC DRUG,TOPICAL,MICONAZOLE NITRATE,998428,,289dd4d1-bed5-42a7-e063-6394a90ace68,3650ee3d-b285-46b9-a80b-e868f22053aa,11523-0544-2,TRUE,VW4H1CYW1K,3.11E+11,Drugs,88677,Bayer Healthcare Pharmaceuticals Inc.,100 Bayer Blvd,N/A,07981-1544,Voluntary: Firm initiated,Press Release,"Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.",D-0238-2022,"LOTRIMIN AF (Miconazole nitrate 2%) Powder Spray NET WT 133g (4.6 OZ) can, packaged as (a) a single pack NDC 11523-0544-2 UPC 3 11017 41025 7; (b) 3 pack, NDC 11523-0544-2, UPC 0 41100 58594 3; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain,       ,","3,816,468 cans",cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.,20211001,20211118,20230626,20211124,"Lot # (a) CV017D9, EXP 10/31/2021; CV01940, EXP 11/30/2021; CV01CD9, EXP 4/30/2022; CV01D9T, CV01DZ3, EXP 6/30/2022; CV01EPP, EXP 7/31/2022; TN000TT, EXP 10/31/2022; TN003CG, EXP 1/31/2023; TN003CH, TN00407, EXP 3/31/2023; TN0041V, EXP 6/30/2023; TN0056W, EXP 7/31/2022; TN005P4, EXP 8/31/2022; TN006MJ, EXP 9/30/2022;   (b) CV01940, CV01940A, EXP 11/30/2021; CV01AP2, EXP 02/28/2022; CV01D9T, CV01D9TA, CV01DZ3, EXP 06/30/2022; CV01EPP, EXP 07/31/2022; TN005P4, EXP 08/31/2022; TN000TT,  TN000TTA, EXP 10/31/2022; TN003CG, EXP 01/31/2023; TN003CH, TN003CHA,   TN00407, TN006TD, TN006TDB, TN00407A, EXP 03/31/2023; TN0041V, EXP 06/30/2023",,,,,,,,,,,,,,,,,3.11E+11,41100585943,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Pulaski,TN,United States,Class II,ANDA206125,CINACALCET,CINACALCET,AvKARE,42291-459,HUMAN PRESCRIPTION DRUG,ORAL,CINACALCET HYDROCHLORIDE,432400,432401,0e8fd624-fbe3-c134-e063-6294a90a01e2,c81dce3a-8f66-4a99-e053-2a95a90a9a10,42291-459-30,,1K860WSG25,,Drugs,95897,AvKARE,615 N 1st St,,38478-2403,Voluntary: Firm initiated,Letter,USA Nationwide,D-0109-2025,"Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30","2,396 bottles","CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.",20241127,20241205,,20241211,"Lot # 44550, Exp 12/31/2024",,42291-460,42291-461,432402,42291-460-30,42291-461-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65862-831,65862-832,65862-833,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Shirley,NY,United States,Class II,NDA021135,VENOFER,IRON SUCROSE,"Fresenius Medical Care Holdings, Inc.",49230-530,HUMAN PRESCRIPTION DRUG,INTRAVENOUS,IRON SUCROSE,1741267,1741268,d169adb0-d1dc-4c19-99b4-f1dce90db380,f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040,49230-530-01,TRUE,FZ7NYF5N8L,3.49E+11,Drugs,95711,"American Regent, Inc.",5 Ramsey Rd,,11967-4701,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0080-2025,"Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02451, NDC: 49230-534-01 (vial), NDC: 49230-534-25 (25 x 5 mL/vial cartons).",,Presence of Particulate Matter: Potential for glass delamination from the vials.,20241111,20241129,,20241211,"Lot#s: 4196, Exp 05/31/2026",,49230-534,,1741270,49230-530-10,49230-530-25,49230-534-01,49230-534-10,49230-534-25,,,,,,,,3.49E+11,,,,,,,,,,,,1741271,M0011718,N0000177913,Iron [CS],Parenteral Iron Replacement [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Lake Forest,IL,United States,Class I,ANDA077908,PROPOFOL,PROPOFOL,"Hospira, Inc.",0409-4699,HUMAN PRESCRIPTION DRUG,INTRAVENOUS,PROPOFOL,1808217,1808222,4fe7d279-304e-4d41-b374-9263fbde9998,28d7ba00-f824-4e55-139a-03f509c099db,0409-4699-50,TRUE,YI7VU623SF,,Drugs,69573,Hospira Inc.,275 N Field Dr,,60045-2579,Voluntary: Firm initiated,Telephone,"Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorolac tromethamine 60 mg/2 mL (30 mg/mL), and Propofol 1% 200 mg/20 mL (10 mg/mL), these lots remained within the control of the distributor and were not further distributed. Distribution was Nationwide for the Vancomycin 1 g product.",D-0389-2015,"Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL  60045, NDC 0409-4699-30.","2,500 vials",Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.,20141006,20150213,20161215,20150225,"One shipment of Lot #: 33-750-DJ; Exp 1SEP2015 to The Harvard Drug Group, Livonia, MI",,0409-6010,,1808224,0409-4699-30,0409-4699-53,0409-4699-33,0409-4699-54,0409-4699-24,0409-6010-02,0409-6010-25,,,,,,,,,,,,,,,,,,,N0000175975,N0000175681,,General Anesthetic [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,General Anesthesia [PE],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Whippany,NJ,United States,Class II,M005,TINACTIN,TOLNAFTATE,Bayer HealthCare LLC.,11523-0777,HUMAN OTC DRUG,TOPICAL,TOLNAFTATE,705934,705936,289df0b8-dadb-2f63-e063-6394a90aa6f4,00a17e61-0d91-41e0-9cbe-c7c0b3093f3c,11523-0777-2,TRUE,06KB629TKV,3.11E+11,Drugs,88677,Bayer Healthcare Pharmaceuticals Inc.,100 Bayer Blvd,N/A,07981-1544,Voluntary: Firm initiated,Press Release,"Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.",D-0245-2022,"Tinactin (Tolnaftate 1%) POWDER SPRAY NET WT 133g (4.6 oz) can, Labeled as (a) Product of  Ireland 86940418, (b)Product of Finland 20006106, (c) Product of Ireland with Instant redeemable coupon ( IRC); Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 3 11017 41009 7, NDC 11523-0777-2.","2,841,012 cans",cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.,20211001,20211118,20230626,20211124,"Lot # (a) CV015YT, EXP 10/31/2021; CV01AE7, EXP 2/28/2022; CV01CY2, EXP 4/30/2022'; CV01E6P, EXP 8/31/2022; TN00085, TN001EK, EXP 10/31/2022; TN001ZV, TN00274, EXP 12/31/2022; TN003CU, EXP 1/31/2023; TN003CV, EXP 3/31/2023; TN0047H, EXP 4/30/2023; TN0047R, EXP 5/31/2023;  (b)TN0067B, EXP 9/30/2022; TN006AT, EXP 12/31/2022; TN006TA, EXP 2/28/2023;  (c) CV01E6PV, CV01E6PD, CV01E6PC, CV01E6PBV, CV01E6PAV, EXP 8/31/2022",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Princeton,NJ,United States,Class III,ANDA203874,AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM,AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM,Dr. Reddy's Laboratories Inc,43598-313,HUMAN PRESCRIPTION DRUG,ORAL,AMLODIPINE BESYLATE,404011,404013,54058ac6-94e2-d2d3-5c46-886b3478fc76,abee4a34-89cc-d886-192c-32582ab8f024,43598-323-30,TRUE,48A5M73Z4Q,3.44E+11,Drugs,71375,"Dr. Reddy's Laboratories, Inc.",107 College Rd E,,08540-6623,Voluntary: Firm initiated,Letter,Nationwide,D-1143-2015,"Amlodipine besylate and Atorvastatin calcium tablets, 5mg/10mg, packaged in a)30-count bottle (NDC 43598-322-30), b) 90-count bottle (NDC 43598-322-90), Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Bachupally, 500 090 India",,Subpotent drug,20150506,20150618,20160331,20150624,"Lot #: a) C401536, Exp 07/2015; b) C401538, Exp 07/2015",,43598-323,43598-320,597967,43598-323-60,43598-323-90,43598-323-05,43598-320-30,43598-320-60,43598-320-90,43598-320-05,43598-317-30,43598-317-60,43598-317-90,43598-317-05,,3.44E+11,3.44E+11,43598-317,43598-322,43598-322-30,43598-322-60,43598-322-90,43598-322-05,43598-319-30,43598-319-60,43598-319-90,43598-319-05,597971,,,,,43598-319,43598-316,43598-314,43598-321,43598-318,43598-315,,597974,597977,597980,597984,597987,597990,597993,,43598-316-30,43598-316-60,43598-316-90,43598-316-05,3.44E+11,3.44E+11,3.44E+11,3.44E+11,3.44E+11,3.44E+11,,,,ATORVASTATIN CALCIUM TRIHYDRATE,,,,,,864V2Q084H,,,,,43598-314-30,43598-314-60,43598-314-90,43598-314-05,43598-321-30,43598-321-60,43598-321-90,43598-321-05,43598-318-30,43598-318-60,43598-318-90,43598-318-05,43598-315-30,43598-315-60,43598-315-90,43598-315-05,43598-313-30,43598-313-60,43598-313-90,43598-313-05,,,,,,,,,,,,,,
Ongoing,"Sinnar, Nashik District",N/A,India,Class II,ANDA090483,AMLODIPINE AND VALSARTAN,AMLODIPINE AND VALSARTAN,Mylan Pharmaceuticals Inc.,0378-1721,HUMAN PRESCRIPTION DRUG,ORAL,AMLODIPINE BESYLATE,722126,722131,97bfe7c1-7e4b-45a1-b045-ff48275f1488,aa7e7d95-520a-461c-b1b3-e588aeb6a613,0378-1721-93,TRUE,80M03YXJ7I,3.04E+11,Drugs,81707,"Mylan Laboratories Limited, (Nashik FDF)","F-4 F-12, Malegaon M.I.D.C., Sinnar",N/A,N/A,Voluntary: Firm initiated,Press Release,"Product was distributed throughout the United States to several major distributors, including Puerto Rico.",D-0320-2019,"Amlodipine and Valsartan Tablets, USP  5/160 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-1721-93.","141,995 HDPE bottles","GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.",20181204,20181214,,20181219,"Lot Numbers:3064084, 3069629, 3073148, 3073149,3076093, 3077772",,0378-1722,0378-1723,722134,0378-1722-93,0378-1723-93,0378-1724-93,,,,,,,,,,3.04E+11,3.04E+11,0378-1724,,,,,,,,,,722137,N0000000070,N0000175561,,Angiotensin 2 Receptor Blocker [EPC],,,,,,,,,,,,,,,,,,,,3.04E+11,,,,,,,,,VALSARTAN,,,,,,864V2Q084H,,,,,,,,,,,,,,,,,,,,,,,,,Angiotensin 2 Receptor Antagonists [MoA],,,,,,,,,,,,,
Ongoing,Seymour,IN,United States,Class II,ANDA215802,LISDEXAMFETAMINE DIMESYLATE,LISDEXAMFETAMINE DIMESYLATE,"Lannett Company, Inc.",0527-4661,HUMAN PRESCRIPTION DRUG,ORAL,LISDEXAMFETAMINE DIMESYLATE,854830,854834,981ca74f-737d-45e5-a3b2-b25256263768,2cedb4c2-1e40-4bc4-b9f4-127150c4afbd,0527-4661-37,TRUE,SJT761GEGS,3.05E+11,Drugs,95630,Lannett Company Inc.,1101 C Ave W,,47274-3342,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0112-2025,"Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC:  0527-4661-37",1608 bottles,Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.,20241025,20241205,,20241211,"Lot: 23274856A, Exp 04/30/2025",,0527-4662,0527-4663,854838,0527-4662-37,0527-4663-37,0527-4664-37,0527-4665-37,0527-4666-37,0527-4667-37,,,,,,,3.05E+11,3.05E+11,0527-4664,0527-4665,,,,,,,,,854842,,,,,0527-4666,0527-4667,,,,,,854846,854850,1593856,,,,,,,,,,3.05E+11,3.05E+11,3.05E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Mahwah,NJ,United States,Class II,ANDA212317,DILTIAZEM HYDROCHLORIDE,DILTIAZEM HYDROCHLORIDE,Northstar Rx LLC,16714-553,HUMAN PRESCRIPTION DRUG,ORAL,DILTIAZEM HYDROCHLORIDE,830865,830869,a11626b3-d7a9-43b0-85d4-38a582acd661,e2511ffe-5821-4f64-a469-f8ef9618b1b5,16714-553-01,TRUE,OLH94387TE,3.17E+11,Drugs,95660,"Glenmark Pharmaceuticals Inc., USA",750 Corporate Dr,,07430-2009,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0097-2025,"Diltiazem Hydrochloride Extended-Release Capsules, USP 90mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-554-01.",4704 bottles,cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.,20241101,20241203,,20241211,"Lot #: 17222452, Exp Date 11/30/2024; 17230607, Exp Date 02/28/2025.",,16714-554,16714-555,830872,16714-554-01,16714-555-01,,,,,,,,,,,3.17E+11,3.17E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Kalamazoo,MI,United States,Class II,NDA050441,CLEOCIN PHOSPHATE,CLINDAMYCIN PHOSPHATE,Pharmacia & Upjohn Company LLC,0009-0728,HUMAN PRESCRIPTION DRUG,INTRAMUSCULAR,CLINDAMYCIN PHOSPHATE,1737244,1737245,e1cef283-1e43-40ae-b892-093b539c3bf4,05a75685-0af5-407c-ac57-e380c882b49d,0009-0870-21,TRUE,EH6D7113I8,,Drugs,65275,Pharmacia & Upjohn LLC,7000 Portage Rd,,49001-0102,Voluntary: Firm initiated,Letter,Nationwide,D-609-2013,"Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL) ADD-Vantage Vial, Rx Only, For Intravenous Use Only, Use Only with the ADD-Vantage diluent container, Distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc, NY, NY 10017, NDC a) 0009-3124-03 and b) 0009-3447-03","898,900 Vials",Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.,20130604,20130620,20140417,20130626,"Lots: a) G34908, Exp 06/14; G53479, Exp 09/14; G63442, G58347, Exp 10/14; G80133, Exp 12/14; and b) G34910, Exp 06/14; G36879, G41005, Exp 07/14; G53478, Exp 09/14; G63444, Exp 10/14; G76317, Exp 11/14.",,0009-0870,0009-0775,1737578,0009-0870-26,0009-0775-20,0009-0775-26,0009-0902-11,0009-0902-18,0009-0728-05,0009-0728-09,0009-3124-01,0009-3124-03,0009-3447-01,0009-3447-03,INTRAVENOUS,,,0009-0902,0009-3124,0009-3381-01,0009-3381-02,0009-3375-01,0009-3375-02,0009-3382-01,0009-3382-02,0009-6582-02,0009-6582-01,1737579,,,,,0009-3447,0009-3381,0009-3375,0009-3382,0009-6582,,,1737581,1737582,205964,309335,309336,309339,685574,685576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,685578,706461,,,,,,,,,,,
Ongoing,Athens,TN,United States,Class II,,,,,,,,,,,,,,,,,Drugs,95826,Midlab Incorporated,140 Private Brand Way,,37303-1401,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0089-2025,"Array Liquid Antiseptic Handwash, Chloroxylenol 0.1%, NET CONTENTS: 128 FL OZ (1 GAL) 3.785 L, FOR DISTRIBUTION EXCLUSIVELY BY GORDON FOOD SERVICE, WYOMING, MI 49509",,cGMP Deviations: Out of specification results for micro in hand soap products.,20241106,20241202,,20241211,Lot 0711241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,"Sinnar, Nashik District",N/A,India,Class II,ANDA090483,AMLODIPINE AND VALSARTAN,AMLODIPINE AND VALSARTAN,Mylan Pharmaceuticals Inc.,0378-1721,HUMAN PRESCRIPTION DRUG,ORAL,AMLODIPINE BESYLATE,722126,722131,97bfe7c1-7e4b-45a1-b045-ff48275f1488,aa7e7d95-520a-461c-b1b3-e588aeb6a613,0378-1721-93,TRUE,80M03YXJ7I,3.04E+11,Drugs,81707,"Mylan Laboratories Limited, (Nashik FDF)","F-4 F-12, Malegaon M.I.D.C., Sinnar",N/A,N/A,Voluntary: Firm initiated,Press Release,"Product was distributed throughout the United States to several major distributors, including Puerto Rico.",D-0323-2019,"Amlodipine and Valsartan Tablets, USP 10/320 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., NDC 0378-1724-93.","84,066 HDPE bottles","GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.",20181204,20181214,,20181219,"Lot Numbers:  3066064, 3069645, 3069646, 3073142, 3073143, 3073144, 3077617",,0378-1722,0378-1723,722134,0378-1722-93,0378-1723-93,0378-1724-93,,,,,,,,,,3.04E+11,3.04E+11,0378-1724,,,,,,,,,,722137,N0000000070,N0000175561,,Angiotensin 2 Receptor Blocker [EPC],,,,,,,,,,,,,,,,,,,,3.04E+11,,,,,,,,,VALSARTAN,,,,,,864V2Q084H,,,,,,,,,,,,,,,,,,,,,,,,,Angiotensin 2 Receptor Antagonists [MoA],,,,,,,,,,,,,
Ongoing,Pennington,NJ,United States,Class III,ANDA206055,ESOMEPRAZOLE MAGNESIUM,ESOMEPRAZOLE MAGNESIUM,Zydus Pharmaceuticals USA Inc.,68382-848,HUMAN PRESCRIPTION DRUG,ORAL,ESOMEPRAZOLE MAGNESIUM DIHYDRATE,692576,692578,bc31956a-671b-4ca3-b9dd-1fdb03003cae,190a4c5b-1547-45d7-b00b-10da4131e2e2,68382-848-94,TRUE,36H71644EQ,,Drugs,95767,Zydus Pharmaceuticals (USA) Inc,73 Route 31 N,,08534-3601,Voluntary: Firm initiated,Letter,USA Nationwide.,D-0102-2025,"Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94.  Packaged in sachets",4404 packs,Labeling: Not Elsewhere Classified - Wrong NDC number,20241114,20241204,,20241211,"Lot#: M408002, Exp 05/31/2026",,68382-849,,,68382-849-94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,East Brunswick,NJ,United States,Class II,ANDA090778,DULOXETINE,DULOXETINE HYDROCHLORIDE,"Rising Pharma Holdings, Inc.",57237-017,HUMAN PRESCRIPTION DRUG,ORAL,DULOXETINE HYDROCHLORIDE,596926,596930,4166006e-ead3-4e01-8b11-07d26ac957ed,ea2dc1a6-22d5-4295-9d39-9bf015dc5a89,57237-017-60,TRUE,9044SC542W,3.57E+11,Drugs,95756,"Rising Pharma Holding, Inc.",2 Tower Center Blvd Ste 1401,,08816-1149,Voluntary: Firm initiated,Letter,Nationwide.,D-0107-2025,"Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99) bottles, Distributed by: Rising Pharmaceuticals, Inc., East Brunswick, NJ","233,003 bottles",CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit,20241119,20241205,,20241211,"a) 30s; DT6023059A, DT6023060A, DT6023065A, DT6023069A, DT6023070A, exp. date Jan-25, DT6023080A, exp. date Feb-25, DT6023093A, exp. date Mar-25, DTC24012A, exp. date Dec-25;  b) 90s; DT6023108A, exp. date Apr-25, DTC23201A, exp. date Aug-25;  c) 1000s;  DT6022160A,  DT6022165A,  DT6022162A,  DT6022164A,  DT6022163A,  DT6022171A,  DT6022169A,  DT6022170A,  DT6022173A, exp. date Nov-24, DT6023009A,  DT6023007A,  DT6023008A,  DT6023011A,  DT6023034B, exp. date Dec-24, DT6023067C, exp. date Jan-25, DT6023114A, exp. date Apr-25, DTC23243A, exp. date Oct-25, DTC24040A, exp. date Dec-25",,57237-018,57237-019,596934,57237-017-99,57237-018-30,57237-018-90,57237-018-99,57237-019-30,57237-019-90,57237-019-99,,,,,,3.57E+11,3.57E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Lake Forest,IL,United States,Class I,NDA200403,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,"Hospira, Inc.",0409-1283,HUMAN PRESCRIPTION DRUG,INTRAMUSCULAR,HYDROMORPHONE HYDROCHLORIDE,897653,897753,8f74252c-9a34-4f85-a62c-e42bbff1a22f,e9c9ef18-7dfc-4322-b2fc-29b934c30f8b,0409-2552-11,TRUE,L960UP2KRW,,Drugs,62854,Hospira Inc.,275 N Field Dr,N/A,60045-2579,Voluntary: Firm initiated,Press Release,Nationwide,D-020-2013,"HYDROmorphone HCl Injection, USP, 2 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-count Carpujects per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1312-30, Barcode (01) 1 030409 131230 9 (carton), (01) 0 030409 131230 2 (cartridge unit).","216,880 cartridge units",Superpotent (Single Ingredient) Drug: The prefilled cartridge unit has been found to be overfilled and contain more than the 1 mL labeled fill volume.,20120815,20121024,20150529,20121031,"Lot 12720LL, Exp 12/01/13",,0409-2552,0409-3356,897756,0409-2552-01,0409-3356-11,0409-3356-01,0409-2540-11,0409-2540-01,0409-3365-11,0409-3365-01,0409-3365-10,0409-1283-03,0409-1283-31,0409-1283-09,INTRAVENOUS,,,0409-2540,0409-3365,0409-1283-10,0409-1283-04,0409-1283-05,0409-1312-03,0409-1312-30,0409-1312-09,0409-1312-10,0409-1304-03,897757,,,,,0409-1312,0409-1304,,,,,,897758,1433251,1724276,1724383,1724644,,,,0409-1304-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SUBCUTANEOUS,,,,,,,,,,
Terminated,New York,NY,United States,Class II,NDA020125,ACCURETIC,QUINAPRIL AND HYDROCHLOROTHIAZIDE,Parke-Davis Div of Pfizer Inc,0071-3112,HUMAN PRESCRIPTION DRUG,ORAL,HYDROCHLOROTHIAZIDE,310796,310797,489727cb-429e-4f04-a973-ae4dc7898519,80e9d61d-9674-4ac4-b84c-79a875d408dd,0071-0223-23,TRUE,0J48LPH2TH,3.01E+11,Drugs,89864,Pfizer Inc.,235 East 42nd Street,,10017-5703,Voluntary: Firm initiated,Press Release,Nationwide,D-0761-2022,"Accuretic (quinapril HCl/hydrochlorothiazide) tablets, 20 mg/12.5 mg*, 90 Tablets, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY. NY 10017, Made in Germany,  NDC 0071-5212-23    .",195 bottles,CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.,20220321,20220406,20240828,20220413,Lot FG5381; Exp. 08/2024,,0071-0223,0071-5212,310809,0071-3112-23,0071-5212-23,0071-7225-23,,,,,,,,,,3.01E+11,3.01E+11,0071-7225,,,,,,,,,,809854,N0000175359,N0000175419,Thiazides [CS],Thiazide Diuretic [EPC],,,,,,,,809858,882559,,,,,,,,,,,3.01E+11,,,,,,,,,QUINAPRIL HYDROCHLORIDE,,M0471776,,Increased Diuresis [PE],,33067B3N2M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Pulaski,TN,United States,Class II,ANDA206125,CINACALCET,CINACALCET,AvKARE,42291-459,HUMAN PRESCRIPTION DRUG,ORAL,CINACALCET HYDROCHLORIDE,432400,432401,0e8fd624-fbe3-c134-e063-6294a90a01e2,c81dce3a-8f66-4a99-e053-2a95a90a9a10,42291-459-30,,1K860WSG25,,Drugs,95897,AvKARE,615 N 1st St,,38478-2403,Voluntary: Firm initiated,Letter,USA Nationwide,D-0110-2025,"Cinacalcet Tablets, 90 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-461-30","2,796 bottles","CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.",20241127,20241205,,20241211,"Lot #: 44405, Exp 12/31/2024",,42291-460,42291-461,432402,42291-460-30,42291-461-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65862-831,65862-832,65862-833,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Athens,TN,United States,Class II,,,,,,,,,,,,,,,,,Drugs,95826,Midlab Incorporated,140 Private Brand Way,,37303-1401,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0092-2025,"Compliance Dishwashing Liquid & Antibacterial Soap, PCMX 0.1%, Net Contents: 1 Gallon, 128 Ounces, 3.785 Liters,  Royal Corporation, 10232 Palm Drive, Santa Fe Springs, CA 90670",,cGMP Deviations: Out of specification results for micro in hand soap products.,20241106,20241202,,20241211,Lot 0711241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Zebulon,NC,United States,Class III,NDA021254,ADVAIR HFA,FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE,GlaxoSmithKline LLC,0173-0715,HUMAN PRESCRIPTION DRUG,RESPIRATORY (INHALATION),FLUTICASONE PROPIONATE,896231,896235,41f42eae-40d8-499e-8b52-d73a98ffc998,dfaca6f9-3277-47b2-319d-1377917cb54c,0173-0715-20,TRUE,6EW8Q962A5,,Drugs,63707,"GlaxoSmithKline, LLC.",1011 North Arendell Ave,N/A,27597-1217,Voluntary: Firm initiated,Letter,Nationwide and Puerto Rico.,D-064-2013,"Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 Metered Actuations, For Oral Inhalation with Advair HFA actuator only, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0715-20.","310,964 Aerosol Units",Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.,20121024,20121123,20140911,20121205,"Lot #: 1ZP2465, Exp Oct-12, 1ZP5224, Exp. Nov-12, 1ZP5455, 1ZP6916, Exp. Dec-12, 1ZP8042, 1ZP9593, Exp Jan-13, 1ZP9900, Exp. Mar-13, 1ZP1134, Exp. Apr-13, 1ZP3190, 2ZP6531, Exp. May-13, 2ZP6924, 2ZP7258, Exp. Jul-13, 2ZP1886, 2ZP9975, 2ZP0027, 2ZP9782, Exp. Sep-13, 2ZP1331, Exp. Oct-13, 2ZP2366, Exp. Nov-13.",,0173-0716,0173-0717,896236,0173-0715-22,0173-0716-20,0173-0716-22,0173-0717-20,0173-0717-22,,,,,,,,,,,,,,,,,,,,896237,,,,,,,,,,,,896239,896243,896244,896245,896267,896271,896272,896273,,,,,,,,,,,,,,SALMETEROL XINAFOATE,,,,,,O2GMZ0LF5W,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,New York,NY,United States,Class II,NDA020125,ACCURETIC,QUINAPRIL AND HYDROCHLOROTHIAZIDE,Parke-Davis Div of Pfizer Inc,0071-3112,HUMAN PRESCRIPTION DRUG,ORAL,HYDROCHLOROTHIAZIDE,310796,310797,489727cb-429e-4f04-a973-ae4dc7898519,80e9d61d-9674-4ac4-b84c-79a875d408dd,0071-0223-23,TRUE,0J48LPH2TH,3.01E+11,Drugs,89864,Pfizer Inc.,235 East 42nd Street,,10017-5703,Voluntary: Firm initiated,Press Release,Nationwide,D-0754-2022,"Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 10 mg/12.5 mg*, 90 Tablets bottles, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany,  NDC 0071-3112-23.",53 bottles,CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.,20220321,20220406,20240828,20220413,Lot FG5379; Exp. 08/2024,,0071-0223,0071-5212,310809,0071-3112-23,0071-5212-23,0071-7225-23,,,,,,,,,,3.01E+11,3.01E+11,0071-7225,,,,,,,,,,809854,N0000175359,N0000175419,Thiazides [CS],Thiazide Diuretic [EPC],,,,,,,,809858,882559,,,,,,,,,,,3.01E+11,,,,,,,,,QUINAPRIL HYDROCHLORIDE,,M0471776,,Increased Diuresis [PE],,33067B3N2M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Sacramento,CA,United States,Class I,,,,,,,,,,,,,,,,,Drugs,95714,Boulla LLC,2108 N ST #7929,,95816,Voluntary: Firm initiated,E-Mail,Nationwide within the United States,D-0083-2025,"VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.com",Unknown,Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.,20241104,20241202,,20241211,"Lot #: 230811, Exp: 08/11/2025",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Columbus,OH,United States,Class II,ANDA201193,OXCARBAZEPINE,OXCARBAZEPINE,Hikma Pharmaceuticals USA Inc.,0054-0199,HUMAN PRESCRIPTION DRUG,ORAL,OXCARBAZEPINE,,,39c18929-4ff4-4d24-82e3-6505e561ff65,45a6d619-9198-45c3-b9fa-1b52325366d3,0054-0199-59,TRUE,VZI5B1W380,,Drugs,66289,Boehringer Ingelheim Roxane Inc,1809 Wilson Rd,,43228-9579,Voluntary: Firm initiated,Letter,Nationwide,D-002-2014,"Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC 0054-0199-59","10,267 bottles",Resuspension Problems: Recalled lot did not meet resuspendability requirements.,20130403,20131120,20140211,20131127,"Lot # 161304B, Exp. OCT 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N0000175753,N0000008486,,Anti-epileptic Agent [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Decreased Central Nervous System Disorganized Electrical Activity [PE],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Camarillo,CA,United States,Class II,ANDA200909,EZETIMIBE AND SIMVASTATIN,EZETIMIBE AND SIMVASTATIN,Golden State Medical Supply,51407-190,HUMAN PRESCRIPTION DRUG,ORAL,EZETIMIBE,476345,476349,0c7b8b84-3a6b-7cb1-e063-6294a90a42a4,88cd0e7b-e8dc-6125-e053-2a95a90aaa27,51407-190-30,,AGG2FN16EV,,Drugs,88866,Golden State Medical Supply Inc.,5187 Camino Ruiz,N/A,93012-8601,Voluntary: Firm initiated,Letter,Distributed to two distributors located in AZ and MO,D-0228-2022,"Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC 51407-193-05",49,Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity,20211014,20211109,20221110,20211117,"GS040048, Exp: 1/2023",,51407-191,51407-192,476350,51407-190-90,51407-190-10,51407-191-30,51407-191-90,51407-191-10,51407-192-30,51407-192-90,51407-192-05,51407-192-10,51407-193-30,51407-193-90,,,,51407-193,,51407-193-05,,,,,,,,476351,N0000175589,N0000000121,,HMG-CoA Reductase Inhibitor [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,SIMVASTATIN,,N0000008553,N0000175911,Decreased Cholesterol Absorption [PE],,EOR26LQQ24,,43598-742,43598-744,43598-743,,,,,,,,,,,,,,,,,,,,,Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA],,,,43598-745,Dietary Cholesterol Absorption Inhibitor [EPC],,,,,,,,
Terminated,Lake Forest,IL,United States,Class II,ANDA075240,LABETALOL HYDROCHLORIDE,LABETALOL HYDROCHLORIDE,"Hospira, Inc.",0409-0125,HUMAN PRESCRIPTION DRUG,INTRAVENOUS,LABETALOL HYDROCHLORIDE,896771,,ea339ea4-9c25-41d1-9256-2dd55f509b6a,abfc6b75-1ed5-41f1-0484-4597488237bc,0409-2267-20,TRUE,1GEV3BAW9J,,Drugs,68296,Hospira Inc.,275 N Field Dr,,60045-2579,Voluntary: Firm initiated,Press Release,Nationwide,D-1424-2014,"Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20","45,448 vials",Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution,20140516,20140708,20170316,20140716,"Lot 36225DD, exp 12/01/2015",,0409-2267,,,0409-2267-54,0409-0125-01,0409-0125-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Miami,FL,United States,Class II,NDA020870,COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM),ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM,"Noven Therapeutics, LLC",68968-0514,HUMAN PRESCRIPTION DRUG,TRANSDERMAL,ESTRADIOL,1251493,1251495,a8dddb67-4c56-4d1d-a4ce-83dc426d33f6,83198ef1-11c4-11e4-9191-0800200c9a66,68968-0514-8,TRUE,9S44LIC7OJ,,Drugs,88342,Noven Pharmaceuticals Inc,11960 Sw 144th St,N/A,33186-6109,Voluntary: Firm initiated,Letter,Nationwide.,D-0725-2021,"Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice Weekly Rx Only a) 2 Systems NDC 68968-0525-2; b) 8 Systems NDC 68968-0525-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186","70,638 boxes",Failed Stability Specifications; out of specification for shear.,20210730,20210813,,20210825,Lots: 88540 Exp. 03/2022; 89118 Exp. 05/2022; 89244 Exp. 07/2022; 89244 (sample lot) Exp. 07/2022,,68968-0525,,1251499,68968-0525-8,68968-0525-2,,,,,,,,,,,,,,,,,,,,,,,1251501,M0447348,N0000175825,Estradiol Congeners [CS],Estrogen [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,NORETHINDRONE ACETATE,,N0000000100,,,,4TI98Z838E,,,,,,,,,,,,,,,,,,,,,,,,,Estrogen Receptor Agonists [MoA],,,,,,,,,,,,,
Ongoing,Athens,TN,United States,Class II,,,,,,,,,,,,,,,,,Drugs,95826,Midlab Incorporated,140 Private Brand Way,,37303-1401,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0091-2025,"Genuine Joe Antibacterial Lotion Soap , Chloroxylenol 0.1%, 1 GALLON (3.78L), Manufactured in the U.S.A. for S.P. Richards Co., Atlanta, GA 30339",,cGMP Deviations: Out of specification results for micro in hand soap products.,20241106,20241202,,20241211,Lot 0711241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,New Delhi,,India,Class II,M017,THERA CARE COLD HOT MEDICATED PATCH,MENTHOL,Veridian Healthcare,71101-954,HUMAN OTC DRUG,TOPICAL,MENTHOL,420222,,20d6f5cc-2c81-74a0-e063-6394a90abfed,b1ce129d-06a1-7755-e053-2995a90abd7d,71101-954-05,TRUE,L7T10EIP3A,8.46E+11,Drugs,95595,Unexo Life Sciences Private Limited,"B16, Sector 4, Bawana Industrial Area",,N/A,Voluntary: Firm initiated,Letter,Nationwide in the US,D-0066-2025,"THERACARE Cold Hot Medicated Patch, Menthol 5%, 5 patches per box, Manufactured for: Veridian Healthcare, LLC, Gurnee, IL  60031 NDC 71101-954-05, UPC 8 45717 00818 1","279,936 patches",cGMP Deficiencies,20241024,20241122,,20241204,UPC 8 45717 00818 1,,,,,,,,,,,,,,,,,8.46E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Eatontown,NJ,United States,Class II,ANDA076558,CIPROFLOXACIN,CIPROFLOXACIN,Hikma Pharmaceuticals USA Inc.,0143-9927,HUMAN PRESCRIPTION DRUG,ORAL,CIPROFLOXACIN HYDROCHLORIDE,,,96b157af-1b98-4a3e-a0ed-6ebc905e633c,3b3d22dc-df09-4910-8c9b-1204eeedbd68,0143-9927-01,TRUE,4BA73M5E37,,Drugs,64100,West-ward Pharmaceutical Corp.,465 Industrial Way W,,07724-2209,Voluntary: Firm initiated,Letter,"GA, AR",D-220-2013,"Ciprofloxacin Tablets USP, 500 mg, 100-count bottle, Rx only, Manufactured for West-ward Pharmaceutical Corp., Eatowntown, NJ 07724 by Hikma Pharmaceuticals, Amman, Jordan, NDC 0143-9928-01","7,136 units",Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ciprofloxacin tablet.,20130206,20130327,20140804,20130403,"Lot #: CB222A, Exp 06/16",,0143-9928,0143-9929,,0143-9927-05,0143-9927-30,0143-9928-01,0143-9928-05,0143-9928-30,0143-9929-01,0143-9929-50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Largo,FL,United States,Class II,ANDA210746,CLOBAZAM,CLOBAZAM,"VistaPharm, LLC",66689-058,HUMAN PRESCRIPTION DRUG,ORAL,CLOBAZAM,1366192,,cd1c5098-0fdf-4923-8b50-0e7c3e62d8f9,879e57c5-47ce-4942-acbb-6263951ba591,66689-058-04,TRUE,2MRO291B4U,,Drugs,89395,"VistaPharm, Inc.",7265 Ulmerton Rd,N/A,33771-4809,Voluntary: Firm initiated,Letter,Nationwide within the United States including Puerto Rico,D-0376-2022,"Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only,  Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04","18,456 bottles",Failed Stability Specifications,20220107,20220118,20241213,20220126,"Lots #: 678900, 682000, 682400, Exp. 5/31/2022; 680600, 680800, 681000 Exp. 5/30/2022; 683200, 685200 Exp. 6/30/2022; 728900, 733100 Exp. Date 12/31/2022; 738600 Exp. 1/31/2023; 740600, 741600 Exp. 2/28/2023; 749800, 750900, 752400 Exp. 3/31/2023; 775700 Exp. 6/30/2023",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N0000175694,M0002356,Benzodiazepines [CS],Benzodiazepine [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N0000182137,N0000185506,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cytochrome P450 2D6 Inhibitors [MoA],,,,,,Cytochrome P450 3A4 Inducers [MoA],,,,,,,
Ongoing,Columbus,OH,United States,Class II,ANDA090778,DULOXETINE,DULOXETINE HYDROCHLORIDE,BluePoint,68001-413,HUMAN PRESCRIPTION DRUG,ORAL,DULOXETINE HYDROCHLORIDE,596926,596930,1a275613-8b5c-f2f7-e063-6294a90ac153,c9492555-6061-47bf-923e-26d4d5528453,68001-413-06,TRUE,9044SC542W,3.68E+11,Drugs,95849,Amerisource Health Services LLC,2550 John Glenn Ave Ste A,,43217-1188,Voluntary: Firm initiated,Letter,"PA, OH, PR",D-0099-2025,"Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx only, 60 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories  NDC 68001-413-06","37,916 bottles",CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit,20241114,20241203,,20241211,"Lots: DT2023001A, DT2023009A, exp date Jan 31, 2025",,68001-414,68001-415,596934,68001-414-04,68001-414-05,68001-414-08,68001-415-04,68001-415-05,68001-415-08,,,,,,,3.68E+11,3.68E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Pulaski,TN,United States,Class II,ANDA213803,SUNITINIB MALATE,SUNITINIB MALATE,AvKARE,42291-901,HUMAN PRESCRIPTION DRUG,ORAL,SUNITINIB MALATE,616279,616285,0772f635-a03d-3c10-e063-6294a90a67ad,0772eb61-ca42-39de-e063-6294a90a6632,42291-901-28,,LVX8N1UT73,,Drugs,95596,AvKARE,615 N 1st St,,38478-2403,Voluntary: Firm initiated,Letter,Nationwide within the United States,D-0104-2025,"Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478.  NDC 42291-902-28",20 bottles,Labeling: Label Mix-Up,20241018,20241204,,20241211,"Lot #: 100049501, Exp. Date 07/31/2026",,42291-902,42291-903,616289,42291-902-28,42291-903-28,42291-904-28,,,,,,,,,,,,42291-904,,,,,,,,,,1541890,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0093-8199,0093-8224,0093-8229,,,,,,,,,,,,,,,,,,,,,,,,,0093-8231,,,,,,,,,
Ongoing,New York,NY,United States,Class I,ANDA077908,PROPOFOL,PROPOFOL,"Hospira, Inc.",0409-4699,HUMAN PRESCRIPTION DRUG,INTRAVENOUS,PROPOFOL,1808217,1808222,4fe7d279-304e-4d41-b374-9263fbde9998,28d7ba00-f824-4e55-139a-03f509c099db,0409-4699-50,TRUE,YI7VU623SF,,Drugs,90785,Pfizer Inc.,235 East 42nd Street,,10017-5703,Voluntary: Firm initiated,Press Release,USA Nationwide,D-1540-2022,"PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA","5,390 vials",Presence of particulate matter,20220822,20220919,,20220921,"Lot#: EA7470, Exp 6/1/2023",,0409-6010,,1808224,0409-4699-30,0409-4699-53,0409-4699-33,0409-4699-54,0409-4699-24,0409-6010-02,0409-6010-25,,,,,,,,,,,,,,,,,,,N0000175975,N0000175681,,General Anesthetic [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,General Anesthesia [PE],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Parsippany,NJ,United States,Class II,ANDA040422,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE","Teva Pharmaceuticals USA, Inc.",0555-0775,HUMAN PRESCRIPTION DRUG,ORAL,AMPHETAMINE ASPARTATE MONOHYDRATE,541363,541878,88468f3d-7d03-4cee-aabf-3abc8c9b5e38,cffbbb15-d776-41ae-a8a6-687f2c07bfa4,0555-0971-02,TRUE,O1ZPV620O4,,Drugs,85712,Teva Pharmaceuticals USA,400 Interpace Pkwy,N/A,07054-1120,Voluntary: Firm initiated,Letter,Nationwide within the United State and Puerto Rico.,D-1286-2020,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 15 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0777-02","41,348 bottles",Some bottles may contain mixed strengths of the product.,20200522,20200604,20210525,20200610,"Lot #: 42617008, Exp. date 10/2021",,0555-0971,0555-0972,541892,0555-0775-02,0555-0972-02,0555-0776-02,0555-0777-02,0555-0973-02,0555-0974-02,,,,,,,,,0555-0776,0555-0777,,,,,,,,,577957,,,,,0555-0973,0555-0974,,,,,,577961,687043,1009145,,,,,,,,,,,,,,,,,,,AMPHETAMINE SULFATE,DEXTROAMPHETAMINE SACCHARATE,,,,,6DPV8NK46S,G83415V073,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DEXTROAMPHETAMINE SULFATE,JJ768O327N,,,,,
Terminated,Parsippany,NJ,United States,Class II,ANDA040422,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE","Teva Pharmaceuticals USA, Inc.",0555-0775,HUMAN PRESCRIPTION DRUG,ORAL,AMPHETAMINE ASPARTATE MONOHYDRATE,541363,541878,88468f3d-7d03-4cee-aabf-3abc8c9b5e38,cffbbb15-d776-41ae-a8a6-687f2c07bfa4,0555-0971-02,TRUE,O1ZPV620O4,,Drugs,90803,Teva Pharmaceuticals USA Inc,400 Interpace Pkwy Bldg A,,07054-1120,Voluntary: Firm initiated,Letter,Nationwide in the US.,D-1539-2022,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, Rx Only, 100 tablets per bottle, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0555-0777-02.","83,703 bottles",Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.,20220829,20220916,20230814,20220921,"Lot #: 100023340, Exp 10/2024",,0555-0971,0555-0972,541892,0555-0775-02,0555-0972-02,0555-0776-02,0555-0777-02,0555-0973-02,0555-0974-02,,,,,,,,,0555-0776,0555-0777,,,,,,,,,577957,,,,,0555-0973,0555-0974,,,,,,577961,687043,1009145,,,,,,,,,,,,,,,,,,,AMPHETAMINE SULFATE,DEXTROAMPHETAMINE SACCHARATE,,,,,6DPV8NK46S,G83415V073,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DEXTROAMPHETAMINE SULFATE,JJ768O327N,,,,,
Terminated,Parsippany,NJ,United States,Class II,NDA208799,AIRDUO DIGIHALER,FLUTICASONE PROPIONATE AND SALMETEROL,"Teva Respiratory, LLC",59310-129,HUMAN PRESCRIPTION DRUG,RESPIRATORY (INHALATION),FLUTICASONE PROPIONATE,2395826,2395828,d1917d37-c04e-4cd3-84fa-ab7f61ef7b0b,ac79cc13-4241-427c-a69b-6b00dafcef00,59310-111-06,TRUE,6EW8Q962A5,3.59E+11,Drugs,88738,Teva Pharmaceuticals USA,400 Interpace Pkwy,N/A,07054-1120,Voluntary: Firm initiated,Letter,USA Nationwide,D-0021-2022,"AirDuo Digihaler 113/14 (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not For Sale, Rx Only, Mktd by: Teva Respiratory, LLC , Frazer, PA 19355, Manufactured in Ireland,  NDC 59310-520-08","10,665 inhalers",Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol,20210922,20211021,20230216,20211027,AFR17A,,59310-111,59310-136,2395829,59310-129-06,59310-136-06,59310-510-08,59310-520-08,59310-530-08,,,,,,,,,,59310-510,59310-520,,,,,,,,,2395831,,,,,59310-530,,,,,,,2395832,2395834,,,,,,,,,,,,,,,,,,,,SALMETEROL XINAFOATE,,,,,,O2GMZ0LF5W,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Fresno,CA,United States,Class II,,,,,,,,,,,,,,,,,Drugs,95819,Generitech Corporation,4967 E Lansing Way,,93727-7408,Voluntary: Firm initiated,E-Mail,CA,D-0111-2025,"10 Irregular Pigmentation, Accelerator, Pigment Fading Activator, Only Your Rx, Nature + Science, 1 fl. oz., 30 mL Bottle, For Professional Use Only, Only YourRx Inc., Chatsworth, CA 91311, Made in USA, Onlyyourrx.com.",77.5lbs,CGMP Deviations: Inconsistency in the water systems.,20241122,20241205,,20241211,"Lot #: 2400017, Exp: 4/30/2026",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Plainsboro,NJ,United States,Class II,ANDA202289,LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE,LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE,Macleods Pharmaceuticals Limited,33342-050,HUMAN PRESCRIPTION DRUG,ORAL,HYDROCHLOROTHIAZIDE,979464,979468,6e1eca59-3423-4834-89c7-e776c53e53da,a04b5622-2c49-4d61-92b1-5dc523af7a24,33342-050-07,TRUE,0J48LPH2TH,3.33E+11,Drugs,90037,Macleods Pharma Usa Inc,666 Plainsboro Rd Bldg 200 Ste 230,N/A,08536-0009,Voluntary: Firm initiated,Letter,Product was distributed nationwide.,D-0836-2022,"Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/25 mg, a) 30-count bottles (NDC# 33342-052-07), b) 90-count bottles (NDC # 33342-052-10)  c) 1000-count bottles (NDC # 33342-052-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536",N/A,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits,20220415,20220503,20231013,20220511,"Lot #   BLM2106B, exp. date 05/2023  BLM2101A, exp. date 01/2025  BLM2102A, exp. date 02/2023  BLM2106A, exp. date 05/2023  BLM2103B, exp. date 02/2023  BLM2104A, exp. date 05/2023  BLM2110A, exp. date 06/2023",,33342-051,33342-052,979471,33342-050-10,33342-050-44,33342-050-12,33342-051-07,33342-051-10,33342-051-44,33342-051-12,33342-052-07,33342-052-10,33342-052-44,33342-052-12,,3.33E+11,3.33E+11,,,,,,,,,,,,N0000175359,N0000175419,Thiazides [CS],Thiazide Diuretic [EPC],,,,,,,,,,,,,,,,,,,,3.33E+11,3.33E+11,3.33E+11,3.33E+11,,,,,,LOSARTAN POTASSIUM,,M0471776,,Increased Diuresis [PE],,3ST302B24A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Waltham,MA,United States,Class III,NDA020171,DELFLEX,"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",Fresenius Medical Care North America,49230-206,HUMAN PRESCRIPTION DRUG,INTRAPERITONEAL,CALCIUM CHLORIDE,,,26cdf03c-19f3-42e1-e063-6394a90a2fd0,bbc5b820-4973-11e2-a192-0002a5d5c51b,49230-206-20,TRUE,M4I0D6VV5M,,Drugs,87907,"Fresenius Medical Care Holdings, Inc.",920 Winter St Bld 950,N/A,02451-1521,Voluntary: Firm initiated,Letter,Nationwide within the United States,D-0610-2021,"DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low magnesium, Low Calcium, packaged in a) 3000 mL bags (NDC 49230-206-30)  and b) 5000mL bags, 2 packs (NDC 49230-206-50), Rx only, Fresenius Medical Care NA, Waltham, MA 02451",285 cases,Temperature Abuse: Product exposed to temperature outside specified limits.,20210428,20210609,20210917,20210616,"Lot #: a) 20SU03060, Exp Date. July 2022; b) 21AU02015, 21AU02038, Exp. Date August 2022",,49230-209,49230-212,,49230-206-30,49230-206-32,49230-206-50,49230-206-60,49230-206-62,49230-206-52,49230-209-23,49230-209-30,49230-209-32,49230-209-50,49230-209-60,,,,,,49230-209-62,49230-209-52,49230-212-23,49230-212-30,49230-212-32,49230-212-50,49230-212-60,49230-212-62,,,,,,,,,,,,,,,,,,,,,49230-212-52,,,,,,,,,,,,,DEXTROSE MONOHYDRATE,MAGNESIUM CHLORIDE,,,,,LX22YL083G,02F3473H9O,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SODIUM CHLORIDE,451W47IQ8X,SODIUM LACTATE,TU7HW0W0QT,,,
Ongoing,Athens,TN,United States,Class II,,,,,,,,,,,,,,,,,Drugs,95826,Midlab Incorporated,140 Private Brand Way,,37303-1401,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0088-2025,"boardwalk ANTIBACTERIAL HANDSOAP REFILL, Chloroxylenol 0.1%, 1 gal. (3.78 L), Manufactured for Essendant Co., One Parkway North, Deerfield, IL 60015",,cGMP Deviations: Out of specification results for micro in hand soap products.,20241106,20241202,,20241211,Lot 0711241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Richmond,VA,United States,Class II,NDA019430,EPIPEN,EPINEPHRINE,Mylan Specialty L.P.,49502-500,HUMAN PRESCRIPTION DRUG,INTRAMUSCULAR,EPINEPHRINE,,,2431ada0-9e96-491f-a281-ffd56e21fbba,7560c201-9246-487c-a13b-6295db04274a,49502-500-01,TRUE,YKH834O4BH,,Drugs,89646,Mckesson Medical-Surgical Inc. Corporate Office,9954 Maryland Drive,Deep Run Iii Ste. 4000,23233,Voluntary: Firm initiated,Letter,USA nationwide.,D-0993-2022,"EPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only, Manufactured for: Mylan Specialty LP., NDC 49502-500-02",5 cartons,cGMP deviations: Temperature abuse,20220413,20220609,20231130,20220615,"McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.     The letters clearly explain that consignees should identify product received from MMS between June 1 and September 30, 2021. A consignee should be able to use its own records to determine whether it received an impacted product from MMS during that timeframe and whether it still has any of that product in inventory. The recall notification letter informs consignees that they may contact Sedgwick if they have any questions.",,49502-501,,,49502-500-02,49502-500-92,49502-501-01,49502-501-02,49502-501-92,,,,,,,,,,,,,,,,,,,,,N0000000209,N0000000245,Catecholamines [CS],alpha-Adrenergic Agonist [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N0000175552,N0000175555,,,,,,,,,,,,,,,,,,,,,,,,,,,,Adrenergic alpha-Agonists [MoA],,,,,beta-Adrenergic Agonist [EPC],Adrenergic beta-Agonists [MoA],,,,,N0000175570,M0003647,Catecholamine [EPC]
Ongoing,Mahwah,NJ,United States,Class II,ANDA212317,DILTIAZEM HYDROCHLORIDE,DILTIAZEM HYDROCHLORIDE,"GLENMARK PHARMACEUTICALS INC., USA",68462-562,HUMAN PRESCRIPTION DRUG,ORAL,DILTIAZEM HYDROCHLORIDE,830865,830869,52b392c0-72cb-4a91-8d27-5cacdb8a7778,fb1606ea-1cff-46fd-b8e5-8135da76436c,68462-850-01,TRUE,OLH94387TE,3.68E+11,Drugs,95660,"Glenmark Pharmaceuticals Inc., USA",750 Corporate Dr,,07430-2009,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0093-2025,"Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-850-01.",34848 bottles,cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.,20241101,20241203,,20241211,"Lot #s: 17222544, Exp. Date 11/30/2024 ; 17230784, Exp Date 03/31/2025; 17231080, Exp. Date 04/30/2025",,68462-850,68462-851,830872,68462-851-01,68462-562-01,,,,,,,,,,,3.68E+11,3.68E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Dublin,OH,United States,Class II,ANDA205209,DARIFENACIN,DARIFENACIN,Torrent Pharmaceuticals Limited,13668-202,HUMAN PRESCRIPTION DRUG,ORAL,DARIFENACIN HYDROBROMIDE,,,47ec85f7-660e-43dc-b84e-452556ad62c7,e84f1ae3-b9a2-4a15-a299-c75373891cc1,13668-202-30,TRUE,CR02EYQ8GV,3.14E+11,Drugs,87512,Cardinal Health Inc.,7000 Cardinal Pl,N/A,43017-1091,Voluntary: Firm initiated,Letter,"FL, GA, SC",D-0583-2021,"Darifenacin Extended-release Tablets 7.5 mg 30 Tablets Rx only Manufactured by: Torrent Pharmaceuticals LTD. Indrad-382 721, India Manufactured for: Torrent Pharma Inc. Basking Ridge, NJ 07920, NDC 13668-202-30",52 bottles,CGMP Deviations: Intermittent exposure to temperature excursion during storage.,20210315,20210524,20240617,20210602,BDZ7G005,,13668-203,,,13668-202-90,13668-202-05,13668-203-30,13668-203-05,13668-203-90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,New Delhi,,India,Class II,,,,,,,,,,,,,,,,,Drugs,95595,Unexo Life Sciences Private Limited,"B16, Sector 4, Bawana Industrial Area",,N/A,Voluntary: Firm initiated,Letter,Nationwide in the US,D-0062-2025,"ABSORBINE jr. Extra Large BACK PATCH, Menthol 5%, 1 extra large patch per box, Distributed By: Absorbine Jr., LLC, Chattanooga, TN 37402 UPC 8 89476 41218 6, UPC 8 89476 41236 0","6,848,820 patches",cGMP Deficiencies,20241024,20241122,,20241204,"UPC 8 89476 41218 6, UPC 8 89476 41236 0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Whippany,NJ,United States,Class I,M005,TINACTIN,TOLNAFTATE,Bayer HealthCare LLC,11523-0165,HUMAN OTC DRUG,TOPICAL,TOLNAFTATE,209674,313421,289de908-7bde-ace6-e063-6294a90a2080,bb878f31-2189-4427-aacf-5bce96d75978,11523-0165-3,TRUE,06KB629TKV,3.11E+11,Drugs,88677,Bayer Healthcare Pharmaceuticals Inc.,100 Bayer Blvd,N/A,07981-1544,Voluntary: Firm initiated,Press Release,"Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.",D-0251-2022,"Tinactin (Tolnaftate 1%) LIQUID SPRAY NET WT150g (5.3 OZ) can,  Labeled as (a) Product of Finland 20006101, (b) Product of Ireland 87022897, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981,  UPC 3 11017 41005 9, NDC 11523-0165-3.","4,990,860 cans",Chemical Contamination: presence of benzene,20211001,20211118,20230626,20211124,"Lot # (a)TN006MX, EXP 10/31/2022; TN00BKV, TN008D1, TN008D2, EXP 3/31/2023;  (b) CV0180B, EXP12/31/2021; TN003C5, EXP 1/31/2023",,,,,,,,,,,,,,,,,3.11E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Mahwah,NJ,United States,Class II,ANDA212317,DILTIAZEM HYDROCHLORIDE,DILTIAZEM HYDROCHLORIDE,"GLENMARK PHARMACEUTICALS INC., USA",68462-562,HUMAN PRESCRIPTION DRUG,ORAL,DILTIAZEM HYDROCHLORIDE,830865,830869,52b392c0-72cb-4a91-8d27-5cacdb8a7778,fb1606ea-1cff-46fd-b8e5-8135da76436c,68462-850-01,TRUE,OLH94387TE,3.68E+11,Drugs,95660,"Glenmark Pharmaceuticals Inc., USA",750 Corporate Dr,,07430-2009,Voluntary: Firm initiated,Letter,Nationwide in the USA,D-0094-2025,"Diltiazem Hydrochloride Extended-Release Capsules, USP 90 mg, Rx Only, 100 Capsules, Manufactured for : Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-851-01.","12,864 bottles",cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.,20241101,20241203,,20241211,"Lot #s 17222452, Exp. Date, 11/30/2024; 17230607, Exp. Date 02/28/2025",,68462-850,68462-851,830872,68462-851-01,68462-562-01,,,,,,,,,,,3.68E+11,3.68E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Miami,FL,United States,Class II,NDA021514,DAYTRANA,METHYLPHENIDATE,"Noven Therapeutics, LLC",68968-5552,HUMAN PRESCRIPTION DRUG,TRANSDERMAL,METHYLPHENIDATE,,,f0b85613-40fb-4ecb-a629-b40fc28cf112,2c312c31-3198-4775-91ab-294e0b4b9e7f,68968-5552-3,TRUE,207ZZ9QZ49,,Drugs,75450,"Noven Pharmaceuticals, Inc.",11960 SW 144th St,,33186-6109,Voluntary: Firm initiated,Letter,Nationwide within the US,D-0429-2017,"Daytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2.2 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5554-3.","364,830 patches",Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.,20160822,20170110,20190320,20170118,"Lot #: 79230, Exp. 02/2017; 77547, Exp.07/2016",,68968-5553,68968-5554,,68968-5553-3,68968-5554-3,68968-5555-3,,,,,,,,,,,,68968-5555,,,,,,,,,,,N0000175739,N0000175729,,Central Nervous System Stimulant [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Central Nervous System Stimulation [PE],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Sacramento,CA,United States,Class I,,,,,,,,,,,,,,,,,Drugs,95714,Boulla LLC,2108 N ST #7929,,95816,Voluntary: Firm initiated,E-Mail,Nationwide within the United States,D-0084-2025,"PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com",Unknown,Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.,20241104,20241202,,20241211,"Lot #: 230811, Exp: 08/11/2025",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Whippany,NJ,United States,Class I,M005,LOTRIMIN DAILY PREVENTION DEO,TOLNAFTATE,Bayer HealthCare LLC.,11523-0010,HUMAN OTC DRUG,TOPICAL,TOLNAFTATE,705934,,289dbd00-e2f2-0998-e063-6394a90ae1a4,9e8bfb78-ad81-93d0-e053-2995a90aa41d,11523-0010-1,TRUE,06KB629TKV,41100587206,Drugs,88677,Bayer Healthcare Pharmaceuticals Inc.,100 Bayer Blvd,N/A,07981-1544,Voluntary: Firm initiated,Press Release,"Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.",D-0249-2022,"Lotrimin AF (Tolnaftate 1%) Daily Prevention deodorant powder spray, NET WT 160g (5.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland,   UPC 0 41100 58720 6, NDC 11523-0010-2.","579,456 cans",Chemical Contamination: presence of benzene,20211001,20211118,20230626,20211124,"Lot # TN0023D, EXP 2/28/2022;  TN004BX, EXP 6/30/2022;",,,,,11523-0010-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Miami,FL,United States,Class II,NDA021514,DAYTRANA,METHYLPHENIDATE,"Noven Therapeutics, LLC",68968-5552,HUMAN PRESCRIPTION DRUG,TRANSDERMAL,METHYLPHENIDATE,,,f0b85613-40fb-4ecb-a629-b40fc28cf112,2c312c31-3198-4775-91ab-294e0b4b9e7f,68968-5552-3,TRUE,207ZZ9QZ49,,Drugs,75450,"Noven Pharmaceuticals, Inc.",11960 SW 144th St,,33186-6109,Voluntary: Firm initiated,Letter,Nationwide within the US,D-0428-2017,"Daytrana (methylphenidate transdermal system) Transdermal Patch, 10 mg over 9 hours (1.1mg/hr), packaged in- 30 count per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc, Miami, FL 33186,  NDC 68968-5552-3","1,068,600 patches",Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.,20160822,20170110,20190320,20170118,"Lot #:  77545, Exp.07/2016; 78035, Exp. 08/2016; 78367, Exp. 10/2016;  79919, Exp. 03/2017.",,68968-5553,68968-5554,,68968-5553-3,68968-5554-3,68968-5555-3,,,,,,,,,,,,68968-5555,,,,,,,,,,,N0000175739,N0000175729,,Central Nervous System Stimulant [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Central Nervous System Stimulation [PE],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,Sacramento,CA,United States,Class I,,,,,,,,,,,,,,,,,Drugs,95714,Boulla LLC,2108 N ST #7929,,95816,Voluntary: Firm initiated,E-Mail,Nationwide within the United States,D-0085-2025,"ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com",Unknown,Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.,20241104,20241202,,20241211,"Lot #: YZM240406, Exp: 04/05/2027",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Dublin,OH,United States,Class II,NDA021929,BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,AstraZeneca Pharmaceuticals LP,0310-7370,HUMAN PRESCRIPTION DRUG,RESPIRATORY (INHALATION),BUDESONIDE,1246288,1246304,dd03d461-e832-4b70-a540-a70fbbfd87f9,1d266fe8-52e3-4f85-a037-c5c1afa15e60,0310-7370-20,TRUE,W34SHF8J2K,,Drugs,87512,Cardinal Health Inc.,7000 Cardinal Pl,N/A,43017-1091,Voluntary: Firm initiated,Letter,"FL, GA, SC",D-0561-2021,"Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol 80/4.5 budesonide 80 mcg/formoterol fumarate dihydrate 4.5 mcg Inhalation Aerosol 120 inhalations Rx only Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, NDC 0310-7372-20",905 inhalers,CGMP Deviations: Intermittent exposure to temperature excursion during storage.,20210315,20210524,20240617,20210602,2000655C00,,0310-7372,,,0310-7372-20,,,,,,,,,,,,,,,,,,,,,,,,,N0000175576,N0000175450,,Corticosteroid [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,FORMOTEROL FUMARATE,,,,,,Q3OKS62Q6X,,,,,,,,,,,,,,,,,,,,,,,,,Corticosteroid Hormone Receptor Agonists [MoA],,,,,,,,,,,,,
Ongoing,East Windsor,NJ,United States,Class II,ANDA206125,CINACALCET,CINACALCET,Aurobindo Pharma Limited,65862-831,HUMAN PRESCRIPTION DRUG,ORAL,CINACALCET HYDROCHLORIDE,432400,432401,5aadf0b6-2c49-48d4-8d22-2fbf99dbf4e6,42e99112-c402-4662-877f-9e3a84dff9f2,65862-831-30,TRUE,1K860WSG25,,Drugs,95730,Aurobindo Pharma USA Inc,279 Princeton Hightstown Rd,,08520-1401,Voluntary: Firm initiated,Letter,USA Nationwide,D-0079-2025,"Cinacalcet Tablets, 90 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-833-30), b) 500-count HDPE bottle (NDC 65862-833-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.  90 mg - 30 Tablets - NDC 65862-833-30 90 mg - 500 Tablets - NDC 65862-833-05",,cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit,20241107,20241129,,20241211,"Lot #: a) CFSC23001A, CFSC23001B, Exp 03/31/2025; b) P2300195, Exp 12/31/2024",,65862-832,65862-833,432402,65862-831-90,65862-831-01,65862-831-05,65862-832-30,65862-832-90,65862-832-01,65862-832-05,65862-833-30,65862-833-90,65862-833-01,65862-833-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Warren,NJ,United States,Class II,NDA020402,ADVIL,IBUPROFEN,Haleon US Holdings LLC,0573-1769,HUMAN OTC DRUG,ORAL,IBUPROFEN,310964,731533,e73468b1-b150-4460-af62-5af281dc562b,1f01c10a-9434-91a4-2ee4-352315a6b610,0573-0169-17,TRUE,WK2XYI10QM,,Drugs,85224,Glaxosmithkline Consumer Healthcare Holdings,184 Liberty Corner Rd,N/A,07059-6796,Voluntary: Firm initiated,Letter,"Product was distributed throughout the United States, including Puerto Rico.",D-1066-2020,"Ibuprofen 200 mg liquid filled capsules  Advil Liqui-Gel Minis, 160 count bottle  NDC 0573-1769-89  NDC 0573-1769-95","446,628 bottles",Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.,20200316,20200326,20211028,20200401,"Batch/Lot Numbers:  R53074, exp. date 10/31/2020, item # F00573176989, 160 ct.   R53075, exp. date 10/31/2020, item # F00573176989, 160 ct.   R53076, exp. date 11/30/2020, item # F00573176989, 160 ct.  R53077, exp. date 11/30/2020, item # F00573176989, 160 ct.  R53081, exp. date 11/30/2020, item # F00573176989, 160 ct.  R53901, exp. date 02/28/2021, item # F00573176989, 160 ct.  R53902, exp. date 03/31/2021, item # F00573176989, 160 ct.  R62780, exp. date 06/30/2021, item # F00573176989, 160 ct.",,0573-0169,0573-0149,,0573-0169-02,0573-0169-19,0573-0169-20,0573-0169-40,0573-0169-11,0573-0169-89,0573-0169-30,0573-0169-31,0573-0169-86,0573-0169-51,0573-0169-43,,,,,,0573-0169-49,0573-0169-52,0573-0169-08,0573-0169-22,0573-0169-13,0573-0169-76,0573-0149-13,0573-0149-04,,N0000000160,M0001335,"Anti-Inflammatory Agents, Non-Steroidal [CS]",Nonsteroidal Anti-inflammatory Drug [EPC],,,,,,,,,,,,,,,,0573-0149-66,0573-0149-91,0573-1769-20,0573-1769-80,,,,,,,,,,,,N0000175722,,,,,,,,,0573-1769-89,0573-1769-14,0573-1769-13,0573-1769-09,0573-1769-02,0573-1769-95,57317698,,,,,,,,,,,,,,Cyclooxygenase Inhibitors [MoA],,,,,,,,,,,,,
Terminated,Waltham,MA,United States,Class III,NDA020171,DELFLEX,"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",Fresenius Medical Care North America,49230-206,HUMAN PRESCRIPTION DRUG,INTRAPERITONEAL,CALCIUM CHLORIDE,,,26d12d04-31c5-1506-e063-6394a90ae5a1,c29bdfa0-4976-11e2-939b-0002a5d5c51b,49230-206-92,TRUE,M4I0D6VV5M,,Drugs,87907,"Fresenius Medical Care Holdings, Inc.",920 Winter St Bld 950,N/A,02451-1521,Voluntary: Firm initiated,Letter,Nationwide within the United States,D-0608-2021,"DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low magnesium, Low Calcium and attached stay safe Exchange set, packaged in a) 2500 mL  (NDC 49230-209-94) and b) 2000mL, packs of 5 (NDC 49230-209-92) Fresenius Medical Care NA, Waltham, MA 02451,",39 cases,Temperature Abuse: Product exposed to temperature outside specified limits.,20210428,20210609,20210917,20210616,"Lot #: a) 20PU02010, Exp. date June 2022 and b) 20SU04033, Exp. date July 2022",,49230-209,49230-212,,49230-206-94,49230-206-95,49230-209-92,49230-209-94,49230-209-95,49230-212-92,49230-212-94,49230-212-95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DEXTROSE MONOHYDRATE,MAGNESIUM CHLORIDE,,,,,LX22YL083G,02F3473H9O,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SODIUM CHLORIDE,451W47IQ8X,SODIUM LACTATE,TU7HW0W0QT,,,
Ongoing,East Brunswick,NJ,United States,Class II,ANDA090778,DULOXETINE,DULOXETINE HYDROCHLORIDE,"Rising Pharma Holdings, Inc.",57237-017,HUMAN PRESCRIPTION DRUG,ORAL,DULOXETINE HYDROCHLORIDE,596926,596930,4166006e-ead3-4e01-8b11-07d26ac957ed,ea2dc1a6-22d5-4295-9d39-9bf015dc5a89,57237-017-60,TRUE,9044SC542W,3.57E+11,Drugs,95756,"Rising Pharma Holding, Inc.",2 Tower Center Blvd Ste 1401,,08816-1149,Voluntary: Firm initiated,Letter,Nationwide.,D-0106-2025,"Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 57237-018-90) and c) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ","122,925 bottles",CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit,20241119,20241205,,20241211,"a) 30s; DT3023019A, exp. date Jan-25 DT3023050A, exp. date Apr-25;  b) 90s; DT3023022A, exp. date Jan-25;  c) 1000s; DT3022108A, DT3022107A, DT3022106A, DT3022111A, DT3022109A, exp. date Nov-24, DT3023001A, DT3023003A, exp. date Dec-24, DT3023024A, DT3023020B, exp. date Jan-25 DT3023027A, DT3023028A, exp. date Feb-25, DT3023034A, exp. date Mar-25, DT3023049A, exp. date Apr-25, DT3023095A, exp. date Jul-25",,57237-018,57237-019,596934,57237-017-99,57237-018-30,57237-018-90,57237-018-99,57237-019-30,57237-019-90,57237-019-99,,,,,,3.57E+11,3.57E+11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,East Windsor,NJ,United States,Class II,ANDA206512,AMLODIPINE AND VALSARTAN,AMLODIPINE AND VALSARTAN,Aurobindo Pharma Limited,65862-737,HUMAN PRESCRIPTION DRUG,ORAL,AMLODIPINE BESYLATE,722126,722131,909d72a6-7116-407e-8ec8-77b9b5798237,7fa25f10-29e0-4162-81a8-9d2e03054ded,65862-737-30,TRUE,80M03YXJ7I,3.66E+11,Drugs,81887,Aurobindo Pharma USA Inc.,279 Princeton Hightstown Rd,,08520-1401,Voluntary: Firm initiated,Press Release,Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.,D-0363-2019,"Amlodipine and Valsartan Tablets USP 5 mg/320 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-738-30.","27,688 bottles","CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.",20181231,20190114,,20190123,"Lot # VMSA17012-A, exp. date 11/2019  Lot # VMSA17013-A, exp. date 11/2019  Lot # VMSA17014-A, exp. date 11/2019  Lot # VMSA17015-A, exp. date 11/2019  Lot # VMSA17016-A, exp. date 11/2019  Lot # VMSA17017-A, exp. date 11/2019",,65862-739,65862-738,722134,65862-737-90,65862-737-10,65862-737-03,65862-739-30,65862-739-90,65862-739-10,65862-739-03,65862-738-30,65862-738-90,65862-738-10,65862-738-03,,3.66E+11,,65862-740,,65862-740-30,65862-740-90,65862-740-10,65862-740-03,,,,,722137,N0000000070,N0000175561,,Angiotensin 2 Receptor Blocker [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,VALSARTAN,,,,,,864V2Q084H,,,,,,,,,,,,,,,,,,,,,,,,,Angiotensin 2 Receptor Antagonists [MoA],,,,,,,,,,,,,
Terminated,Richmond,VA,United States,Class II,M018,GENTEAL,"MINERAL OIL, WHITE PETROLATUM","Alcon Laboratories, Inc.",0065-0518,HUMAN OTC DRUG,OPHTHALMIC,MINERAL OIL,706820,,d09a2d41-4976-47b8-827c-5082741f83b4,9d5998a7-4f59-4293-87da-8419650a524d,0065-0518-01,TRUE,T5L8T28FGP,3.01E+11,Drugs,90553,Mckesson Medical-Surgical Inc. Corporate Office,9954 Maryland Drive,Deep Run Iii Ste. 4000,23233,Voluntary: Firm initiated,Letter,Nationwide in the USA.,D-1320-2022,"GenTeal Tears, Lubricant Eye Ointment, Night-Time Ointment, Sterile, 3.5 gm (0.12 FL OZ) per box, Alcon, NDC 0065-0518-01.",40 boxes,CGMP Deviations: products were stored outside the drug label specifications.,20220629,20220805,20240213,20220817,Part# 30065051801,,,,,3006505180,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PETROLATUM,,,,,,4T6H12BN9U,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Princeton,NJ,United States,Class II,ANDA201049,PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE,PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE,Sandoz Inc,0781-5634,HUMAN PRESCRIPTION DRUG,ORAL,GLIMEPIRIDE,647237,647239,724cb72e-023e-409c-8979-3a380a2fdc0a,2aab19ce-1e5e-44ee-85e5-d8f125f9bb1a,0781-5634-31,TRUE,JQT35NPK6C,3.08E+11,Drugs,76515,Sandoz Inc,100 College Rd W,N/A,08540-6604,Voluntary: Firm initiated,Letter,Nationwide,D-0515-2017,"Pioglitazone and Glimepiride Tablets, USP, 30 mg/4 mg, 30 count bottles, Rx only, Manufactured by Lek Pharmaceuticals d.d., Verovskova Ulica 57, Ljubljana, - SI-1526, Slovenia ---  NDC 0781-5635-31",N/A,Failed Dissolution Specifications,20170210,20170309,20171024,20170315,Lot FY3669 with expiry 11/2017,,0781-5635,,,0781-5634-10,0781-5635-31,0781-5635-10,,,,,,,,,,3.08E+11,,,,,,,,,,,,,N0000175608,M0020795,Sulfonylurea Compounds [CS],Sulfonylurea [EPC],,,,,,,,,,,,,,,,,,,,,,,,,,,,,PIOGLITAZONE HYDROCHLORIDE,,,,,,6KY687524K,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ongoing,New Delhi,,India,Class II,,,,,,,,,,,,,,,,,Drugs,95595,Unexo Life Sciences Private Limited,"B16, Sector 4, Bawana Industrial Area",,N/A,Voluntary: Firm initiated,Letter,Nationwide in the US,D-0063-2025,"ABSORBINE jr ULTRA STRENGTH PAIN PATCH, Menthol 6.5%, 1 patch per box, Distributed By: Absorbine Jr. LLC, Chattanooga, TN 37402 UPC 8 89476 41318 3, UPC 8 89476 41336 7","4,968,000 patches",cGMP Deficiencies,20241024,20241122,,20241204,"UPC 8 89476 41318 3, UPC 8 89476 41336 7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Terminated,Vadodara,N/A,India,Class II,ANDA090579,AMPICILLIN AND SULBACTAM,AMPICILLIN SODIUM AND SULBACTAM SODIUM,Xellia Pharmaceuticals USA LLC,70594-081,HUMAN PRESCRIPTION DRUG,INTRAMUSCULAR,AMPICILLIN SODIUM,,,ec431dfa-fe17-4e43-acf9-60eee408cc6b,7161f386-6373-4db5-8dfd-d7ddf38ec2f1,70594-081-01,TRUE,JFN36L5S8K,,Drugs,92341,Astral SteriTech Private Ltd.,911 G I D C Makarpura,N/A,N/A,Voluntary: Firm initiated,Letter,Nationwide within the United States,D-0602-2023,"Ampicillin and Sulbactam for Injection, USP 3 grams per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-082-02","591,160 vials",Lack of Assurance of Sterility,20230515,20230518,20240405,20230524,All lots within expiry.,,70594-082,,,70594-081-02,70594-082-01,70594-082-02,,,,,,,,,INTRAVENOUS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SULBACTAM SODIUM,,,,,,DKQ4T82YE6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
